Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.



Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global


Q3 2023

  • Get Stage 1 white paper out for public review before end of October.
  • Complete background work for Stage 2.



Objectives & Deliverables

Timelines 

Finalise Stage 1 of draft White Paper

Q4 2023